Animalcare has taken over as the UK distributor of Danilon Gold, the leading equine pain management NSAID.
With low ulcerogenic potential and excellent compliance, Danilon Gold is trusted by many owners. It is used to relieve the pain caused by musculoskeletal conditions, such as osteoarthritis (OA), bursitis, laminitis, and soft tissue inflammation in their horses.
Some oral NSAIDs have been shown to increase the risk of gastric irritation – a potential cause for concern for both veterinary surgeons and owners, particularly for the treatment of chronic conditions. However, in gastric studies, horses given Danilon Gold showed a reduced number of ulcers and those that did appear were less severe. The area of gastric mucosa affected was also five times less.
Accurate administration is critical for clinical success. To support this, Danilon Gold is presented in a coloured granule formulation and is now available in both 3 grams and 10 grams sachets. Acceptance by the horse is also key and Danilon Gold’s palatability offers excellent proven voluntary intake.
Animalcare will officially re-launch Danilon at this year’s BEVA Congress at the ACC in Liverpool in early September 2022.
Commenting, Animalcare Brand Manager Kai Crawshaw said: “As the original marketing authorisation holder of Danilon Gold, we are delighted that we are now distributing this incredible product in the UK.
“Danilon joins our focused suite of products for veterinarians to help them ensure the optimum health and welfare of their equine patients. We can’t wait to celebrate the launch at BEVA Congress.”
